{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:44:26Z","timestamp":1775555066744,"version":"3.50.1"},"reference-count":42,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/or.2016.4658","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T11:34:45Z","timestamp":1457350485000},"page":"2673-2680","source":"Crossref","is-referenced-by-count":5,"title":["Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas"],"prefix":"10.3892","volume":"35","author":[{"given":"LENKA","family":"ZLAMALIKOVA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOJMIR","family":"MOULIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVID","family":"SALEK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIRI","family":"JARKOVSKY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAN","family":"SMARDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JANA","family":"SMARDOVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"key20180107211007_b1-or-35-05-2673","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0968-0004(00)89005-2","article-title":"D-type cyclins","volume":"20","author":"Sherr","year":"1995","journal-title":"Trends Biochem Sci"},{"key":"key20180107211007_b2-or-35-05-2673","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20180107211007_b3-or-35-05-2673","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"key20180107211007_b4-or-35-05-2673","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/path.1711720303","article-title":"Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein","volume":"172","author":"Bartkova","year":"1994","journal-title":"J Pathol"},{"key":"key20180107211007_b5-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(\u2212) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"key":"key20180107211007_b6-or-35-05-2673","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th edition"},{"key":"key20180107211007_b7-or-35-05-2673","first-page":"2732","article-title":"Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma","volume":"53","author":"Ye","year":"1993","journal-title":"Cancer Res"},{"key":"key20180107211007_b8-or-35-05-2673","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","article-title":"Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma","volume":"90","author":"Gascoyne","year":"1997","journal-title":"Blood"},{"key":"key20180107211007_b9-or-35-05-2673","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MyC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"key20180107211007_b10-or-35-05-2673","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107211007_b11-or-35-05-2673","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: Report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"120","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"key20180107211007_b12-or-35-05-2673","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"key20180107211007_b13-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107211007_b14-or-35-05-2673","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MyC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"key20180107211007_b15-or-35-05-2673","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","article-title":"A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus","volume":"129","author":"Ehinger","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"key20180107211007_b16-or-35-05-2673","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2559.2008.03042.x","article-title":"Cyclin D1-positive diffuse large B-cell lymphoma","volume":"52","author":"Rodriguez-Justo","year":"2008","journal-title":"Histopathology"},{"key":"key20180107211007_b17-or-35-05-2673","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/PAI.0b013e318182d2aa","article-title":"CD5 negative, cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleen","volume":"17","author":"Teruya-Feldstein","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20180107211007_b18-or-35-05-2673","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/modpathol.2009.173","article-title":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: Lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes","volume":"23","author":"Metcalf","year":"2010","journal-title":"Mod Pathol"},{"key":"key20180107211007_b19-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.humpath.2010.11.015","article-title":"CD5(\u2212) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single case","volume":"42","author":"Lucioni","year":"2011","journal-title":"Hum Pathol"},{"key":"key20180107211007_b20-or-35-05-2673","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/10428194.2010.540361","article-title":"Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus","volume":"52","author":"Vela-Ch\u00e1vez","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"key20180107211007_b21-or-35-05-2673","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","article-title":"SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma","volume":"61","author":"Hsiao","year":"2012","journal-title":"Histopathology"},{"key":"key20180107211007_b22-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/modpathol.3800434","article-title":"Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma","volume":"18","author":"Hans","year":"2005","journal-title":"Mod Pathol"},{"key":"key20180107211007_b23-or-35-05-2673","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2559.2007.02721.x","article-title":"Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients","volume":"51","author":"Amen","year":"2007","journal-title":"Histopathology"},{"key":"key20180107211007_b24-or-35-05-2673","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1746-1596-8-81","article-title":"De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression","volume":"8","author":"Igawa","year":"2013","journal-title":"Diagn Pathol"},{"key":"key20180107211007_b25-or-35-05-2673","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V99.3.815","article-title":"De novo CD5+ diffuse large B-cell lymphoma: A clinicopathologic study of 109 patients","volume":"99","author":"Yamaguchi","year":"2002","journal-title":"Blood"},{"key":"key20180107211007_b26-or-35-05-2673","first-page":"729","article-title":"Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma","volume":"8","author":"Filipits","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key20180107211007_b27-or-35-05-2673","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jcp.2008.063701","article-title":"Complex analysis of cyclin D1 expression in mantle cell lymphoma: Two cyclin D1-negative cases detected","volume":"62","author":"Stefancikova","year":"2009","journal-title":"J Clin Pathol"},{"key":"key20180107211007_b28-or-35-05-2673","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"key20180107211007_b29-or-35-05-2673","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","article-title":"Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma","volume":"208","author":"Muris","year":"2006","journal-title":"J Pathol"},{"key":"key20180107211007_b30-or-35-05-2673","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.leukres.2003.12.008","article-title":"Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta\/lambda type immunoglobulin","volume":"28","author":"Matsuo","year":"2004","journal-title":"Leuk Res"},{"key":"key20180107211007_b31-or-35-05-2673","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood.V84.10.3413.3413","article-title":"Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes","volume":"84","author":"Szepesi","year":"1994","journal-title":"Blood"},{"key":"key20180107211007_b32-or-35-05-2673","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/clinchem\/47.2.195","article-title":"Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: Utility in the diagnosis of mantle cell lymphoma","volume":"47","author":"Bijwaard","year":"2001","journal-title":"Clin Chem"},{"key":"key20180107211007_b33-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/1042819031000079168","article-title":"Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: Comparison with FISH and immunohistochemistry","volume":"44","author":"Hui","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"key20180107211007_b34-or-35-05-2673","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/PDM.0b013e318146959a","article-title":"Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders","volume":"17","author":"Brizova","year":"2008","journal-title":"Diagn Mol Pathol"},{"key":"key20180107211007_b35-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s12032-011-9937-5","article-title":"The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases","volume":"29","author":"Cao","year":"2012","journal-title":"Med Oncol"},{"key":"key20180107211007_b36-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3324\/haematol.2009.010173","article-title":"Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR","volume":"94","author":"Quintanilla-Martinez","year":"2009","journal-title":"Haematologica"},{"key":"key20180107211007_b37-or-35-05-2673","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<543::AID-IJC7>3.0.CO;2-3","article-title":"Expression of cyclin D2 and D3 in lymphoid lesions","volume":"81","author":"Teramoto","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107211007_b38-or-35-05-2673","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1309\/8KF0-0Y0C-2F4L-UHXL","article-title":"Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features","volume":"115","author":"M\u00f8ller","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"key20180107211007_b39-or-35-05-2673","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/cncr.28664","article-title":"Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"120","author":"Ok","year":"2014","journal-title":"Cancer"},{"key":"key20180107211007_b40-or-35-05-2673","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0000000000000120","article-title":"Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements","volume":"38","author":"Juskevicius","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key20180107211007_b41-or-35-05-2673","first-page":"449","article-title":"Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas","volume":"18","author":"Bai","year":"2003","journal-title":"Histol Histopathol"},{"key":"key20180107211007_b42-or-35-05-2673","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1182\/blood-2008-02-136374","article-title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"111","author":"Malumbres","year":"2008","journal-title":"Blood"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4658\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T19:59:37Z","timestamp":1600286377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,3,7]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/or.2016.4658"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4658","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}